Glial fibrillary acidic protein (GFAP), an astrocytic cytoskeletal protein, can be measured in blood samples, and has been associated with Alzheimer’s disease (AD). This evidence concerns the gene GFAP and early-onset autosomal dominant Alzheimer disease.